Douglas Pharmaceuticals Europe Limited
Douglas Pharmaceuticals Europe Limited, a prominent player in the pharmaceutical industry, is headquartered in New Zealand (NZ) and operates extensively across Europe. Founded in 1990, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded pharmaceuticals. With a focus on prescription medications, Douglas Pharmaceuticals is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas. The company’s unique approach to formulation and production has positioned it favourably within the competitive landscape. Notable achievements include a robust portfolio of products that meet stringent regulatory standards, ensuring safety and efficacy for patients. Douglas Pharmaceuticals continues to expand its market presence, driven by a dedication to improving health outcomes across Europe and beyond.
DitchCarbon Score
How does Douglas Pharmaceuticals Europe Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Douglas Pharmaceuticals Europe Limited's score of 26 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Douglas Pharmaceuticals Europe Limited's reported carbon emissions
Douglas Pharmaceuticals Europe Limited, headquartered in New Zealand, has set a long-term commitment to achieve net zero carbon emissions by 2050. This ambitious target encompasses all scopes of emissions, reflecting a comprehensive approach to climate action. While specific emissions data for the most recent year is not available, the company is actively working towards reducing its carbon footprint through various initiatives. By aiming for net zero, Douglas Pharmaceuticals demonstrates its dedication to sustainability and aligns with industry standards for climate responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Douglas Pharmaceuticals Europe Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
